Dr Matthew Bull

BSc MSc PhD Auck.

Biography

Postdoctoral research fellow at the Auckland Cancer Society Research Centre with the Translational Therapeutics Team, led by Associate Professor Adam Patterson.

Research | Current

  • Ongoing development of TH-4000, a hypoxia-selective tyrosine kinase inhibitor (TKI) curently in Phase 2 clincial trials for lung cancer and Head/Neck cancer in USA and Australia
  • Development of additional hypoxia-selective TKI prodrugs
  • Development of the hypoxia-selective analogues of the prodrug PR-104

Areas of expertise

  • Pharmacokinetics
  • In vitro metabolism
  • Bioanalysis (HPLC, LC/MS/MS, SPR etc)
  • Hypoxia activated prodrugs
  • Cancer drug development

Selected publications and creative works (Research Outputs)

Contact details

Primary location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 005
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Social links